1. Home
  2. GNLX
  3. GNLX News

Latest Genelux Corporation (GNLX) News on January 22, 2025

Genelux doses first subject in Phase II trial of NSCLC treatment

Clinical Trials Arena

3 months ago

Genelux doses first subject in Phase II trial of NSCLC treatment

MT Newswires

8 months ago

Top Midday Decliners

MT Newswires

8 months ago

Top Premarket Gainers

Share on Social Networks: